TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 3 | 9 | 5 | 34 | 3 | -88 | -6 |
| P | %wins | 100 | 100 | 100 | 100 | 100 | 0 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/14/24 16:34 | 3/14/24 | CGTX | Cognition Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Ricciardi Lisa | NY | DO | CEO,P | P | 10 | 1.75 | 0 | 6 | 2 | 291 | D | ||||||||||||||
11/16/22 08:31 | 11/15/22 | CGTX | Cognition Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Ricciardi Lisa | NY | DO | CEO,P | P | 16 | 1.30 | 0 | 12 | 96 | 25 | D | ||||||||||||||
10/14/21 21:46 | 10/13/21 | CGTX | Cognition Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Ricciardi Lisa | NY | DO | CEO,P | P | 150 | 12.00 | 0 | 13 | New | 13 | D | ||||||||||||||
7/26/17 16:49 | 7/25/17 | CFRX | Contrafect Corp | DE | Health | Drug | Pharmaceutical Preparations | Ricciardi Lisa | NY | D | P.d | 12 | 1.24 | 0 | 10 | New | 10 | D | |||||||||||||||
5/14/15 12:46 | 5/12/15 | CMRX | Chimerix Inc | DE | Health | Drug | Pharmaceutical Preparations | Ricciardi Lisa | NC | D | P | 75 | 38.54 | 13 | 2 | New | 2 | D | 89 | 129 | 22 | 0 | 4 | -3 | 6 | 6 | 3 | 9 | 5 | 34 | 3 | -88 | |
11/25/08 17:29 | 11/24/08 | SEPR | Sepracor Inc /de/ | DE | Health | Drug | Pharmaceutical Preparations | Ricciardi Lisa | MA | D | P | 47 | 11.85 | 0 | 4 | 80 | 9 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |